Showing codes C9026 (Injection, vedolizumab, 1 mg) — C9056 (Injection, givosiran, 0.5 mg)

C9026 - Injection, vedolizumab
Long description: Injection, vedolizumab, 1 mg
Code added date: 20141001.
Code effective date: 20160101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9027 - Injection, pembrolizumab
Long description: Injection, pembrolizumab, 1 mg
Code added date: 20150101.
Code effective date: 20160101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9028 - Inj. inotuzumab ozogamicin
Long description: Injection, inotuzumab ozogamicin, 0.1 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9029 - Injection, guselkumab
Long description: Injection, guselkumab, 1 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9030 - Inj copanlisib
Long description: Injection, copanlisib, 1 mg
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9031 - Lutetium lu 177 dotatate, tx
Long description: Lutetium lu 177, dotatate, therapeutic, 1 mci
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9032 - Voretigene neparvovec-rzyl
Long description: Injection, voretigene neparvovec-rzyl, 1 billion vector genome
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9033 - Inj, akynzeo
Long description: Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
Code added date: 20181001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9034 - Injection, dexamethasone 9%
Long description: Injection, dexamethasone 9%, intraocular, 1 mcg
Code added date: 20181001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9035 - Injection, aristada initio
Long description: Injection, aripiprazole lauroxil (aristada initio), 1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9036 - Injection, patisiran
Long description: Injection, patisiran, 0.1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9037 - Injection, risperidone
Long description: Injection, risperidone (perseris), 0.5 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9038 - Inj mogamulizumab-kpkc
Long description: Injection, mogamulizumab-kpkc, 1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9039 - Injection, plazomicin
Long description: Injection, plazomicin, 5 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9040 - Injection, fremanezumab-vfrm
Long description: Injection, fremanezumab-vfrm, 1mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9041 - Inj, coagulation factor xa
Long description: Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
Code added date: 20190401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9042 - Inj., belrapzo 1 mg
Long description: Injection, bendamustine hcl (belrapzo), 1 mg
Code added date: 20190401.
Code effective date: 20190701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9043 - Injection, levoleucovorin
Long description: Injection, levoleucovorin, 1 mg
Code added date: 20190401.
Code effective date: 20200101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9044 - Injection, cemiplimab-rwlc
Long description: Injection, cemiplimab-rwlc, 1 mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9045 - Moxetumomab pasudotox-tdfk
Long description: Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9046 - Cocaine hcl nasal (goprelto)
Long description: Cocaine hydrochloride nasal solution (goprelto), 1 mg
Code added date: 20190401.
Code effective date: 20230101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9047 - Injection, caplacizumab-yhdp
Long description: Injection, caplacizumab-yhdp, 1 mg
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9048 - Dexamethasone ophth insert
Long description: Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9049 - Injection, tagraxofusp-erzs
Long description: Injection, tagraxofusp-erzs, 10 mcg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9050 - Injection, emapalumab-lzsg
Long description: Injection, emapalumab-lzsg, 1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9051 - Injection, omadacycline
Long description: Injection, omadacycline, 1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9052 - Injection, ravulizumab-cwv
Long description: Injection, ravulizumab-cwvz, 10 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9053 - Inj, crizanlizumab-tmca
Long description: Injection, crizanlizumab-tmca, 1 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9054 - Injection, lefamulin
Long description: Injection, lefamulin (xenleta), 1 mg
Code added date: 20200101.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9055 - Inj, brexanolone
Long description: Injection, brexanolone, 1mg
Code added date: 20200101.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9056 - Injection, givosiran
Long description: Injection, givosiran, 0.5 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF